Suppr超能文献

基于模拟肿瘤样本的肿瘤含量估计方法的比较分析,确定了它们对癌症全基因组测序中体细胞变异检测的影响。

Comparative analysis of tumor content estimation methods based on simu- lated tumor samples identified their impact on somatic variant detection in cancer whole genome sequencing.

机构信息

Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute.

SRL Inc.

出版信息

Biomed Res. 2023;44(4):161-171. doi: 10.2220/biomedres.44.161.

Abstract

Whole genome sequencing (WGS) in cancer genomics has become widespread with recent technological innovations, and the amount and types of information obtained from WGS are increasing rapidly. Appropriate interpretation of results is becoming increasingly important in clinical applications. This study aimed to evaluate the accuracy of tumor content estimation and its impact on somatic variant detection, using 100 simulated tumor samples covering 10-100% tumor content constructed from the sequencing data of cell line models. Extensive analysis revealed that the estimation results varied among computational analytical methods. Notably, there was a large discrepancy in low tumor content (≤ 30%). The reproducibility decreased in cases wherein chromosome-scale copy number changes were observed in normal cells. The minimum tumor content required to detect somatic alterations was estimated to be 10-30%. Identification of whole genome doubling was achieved with the lowest tumor content, followed by single nucleotide variation/insertion or deletion, structural variation, and copy number variation. Tumor content had a significantly higher impact on the false negatives than the false positives in variant calls. Results should be interpreted cautiously for samples wherein tumor content is a concern. These results can form the basis of developing important guidelines for evaluating cancer WGS.

摘要

在癌症基因组学中,随着最近技术创新的发展,全基因组测序(WGS)已经得到了广泛应用,并且从 WGS 中获得的信息量和类型正在迅速增加。在临床应用中,对结果进行适当的解释变得越来越重要。本研究旨在评估使用从细胞系模型的测序数据构建的 100 个涵盖 10-100%肿瘤含量的模拟肿瘤样本,对肿瘤含量估计的准确性及其对体细胞变异检测的影响进行评估。广泛的分析表明,估计结果因计算分析方法而异。值得注意的是,在低肿瘤含量(≤30%)时存在很大差异。在正常细胞中观察到染色体规模的拷贝数变化的情况下,重现性降低。估计检测体细胞改变所需的最小肿瘤含量为 10-30%。通过最低的肿瘤含量可以识别全基因组倍增,其次是单核苷酸变异/插入或缺失、结构变异和拷贝数变异。在变异调用中,肿瘤含量对假阴性的影响明显高于假阳性。对于肿瘤含量存在问题的样本,结果应谨慎解释。这些结果可以为评估癌症 WGS 制定重要指南提供依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验